Concepedia

Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13

Kevin D. Freeman‐Cook, Lawrence A. Reiter, Mark C. Noe, Amy S. Antipas, Dennis E. Danley, Kaushik Datta, James T. Downs, Shane A. Eisenbeis, James D. Eskra, David J. Garmene,

Bioorganic & Medicinal Chemistry Letters · 2007 · 24 citations · 32 references

DOIFull text

Open access

Concepts

References

32

Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.

R. Clark Billinghurst, Leif Dahlberg, Mirela Ionescu et al. · Journal of Clinical Investigation · 1997 · 975 citations · Full text

, , +14

Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.

Peter G. Mitchell, Holly A. Magna, Lucy Reeves et al. · Journal of Clinical Investigation · 1996 · 943 citations · Full text

, , +15

Biochemical Characterization of Human Collagenase-3

Vera Knäuper, Carlos López-Otı́n, Bryan Ronain Smith et al. · Journal of Biological Chemistry · 1996 · 879 citations · Full text

, , +14

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.

Slawomir Wojtowicz‐Praga, Jeff Torri, Michael D. Johnson et al. · Journal of Clinical Oncology · 1998 · 254 citations

, , +9

Broad‐spectrum matrix metalloproteinase inhibitor marimastat–induced musculoskeletal side effects in rats

Richard R. Renkiewicz, Luping Qiu, Charles A. Lesch et al. · Arthritis & Rheumatism · 2003 · 170 citations

, , +17